Publication: SEA 2022 Standards for Global Control of Cardiovascular Risk.
dc.contributor.author | Mostaza, Jose Maria | |
dc.contributor.author | Pintó, Xavier | |
dc.contributor.author | Armario, Pedro | |
dc.contributor.author | Masana, Luis | |
dc.contributor.author | Real, José T | |
dc.contributor.author | Valdivielso, Pedro | |
dc.contributor.author | Arrobas-Velilla, Teresa | |
dc.contributor.author | Baeza-Trinidad, Ramón | |
dc.contributor.author | Calmarza, Pilar | |
dc.contributor.author | Cebollada, Jesús | |
dc.contributor.author | Civera-Andrés, M | |
dc.contributor.author | Cuende Melero, J I | |
dc.contributor.author | Díaz-Díaz, J L | |
dc.contributor.author | Fernández Pardo, J | |
dc.contributor.author | Guijarro, C | |
dc.contributor.author | Jericó, C | |
dc.contributor.author | Laclaustra, M | |
dc.contributor.author | Lahoz, C | |
dc.contributor.author | López-Miranda, J | |
dc.contributor.author | Martínez-Hervás, S | |
dc.contributor.author | Muñiz-Grijalvo, O | |
dc.contributor.author | Páramo, J A | |
dc.contributor.author | Pascual, V | |
dc.contributor.author | Pedro-Botet, J | |
dc.contributor.author | Pérez-Martínez, P | |
dc.contributor.author | Plana, N | |
dc.contributor.author | Puzo, J | |
dc.contributor.author | Sánchez Chaparro, M Á | |
dc.contributor.author | Vila, L | |
dc.date.accessioned | 2023-05-03T14:46:26Z | |
dc.date.available | 2023-05-03T14:46:26Z | |
dc.date.issued | 2022-01-25 | |
dc.description.abstract | One of the objectives of the Spanish Society of Arteriosclerosis is to contribute to better knowledge of vascular disease, its prevention and treatment. It is well known that cardiovascular diseases are the leading cause of death in our country and entail a high degree of disability and health care costs. Arteriosclerosis is a multifactorial disease and therefore its prevention requires a global approach that takes into account the different risk factors with which it is associated. Therefore, this document summarizes the current level of knowledge and includes recommendations and procedures to be followed in patients with established cardiovascular disease or at high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or requested for those in special situations. It also includes vascular risk estimation, the diagnostic criteria of the different entities that are cardiovascular risk factors, and makes general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not usually referenced in the literature, such as the organization of a vascular risk consultation. | |
dc.identifier.doi | 10.1016/j.arteri.2021.11.003 | |
dc.identifier.essn | 1578-1879 | |
dc.identifier.pmid | 35090775 | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.arteri.2021.11.003 | |
dc.identifier.uri | http://hdl.handle.net/10668/22022 | |
dc.issue.number | 3 | |
dc.journal.title | Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis | |
dc.journal.titleabbreviation | Clin Investig Arterioscler | |
dc.language.iso | en | |
dc.language.iso | es | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.organization | Hospital Universitario Virgen de la Victoria | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.organization | Hospital Universitario Virgen Macarena | |
dc.organization | Hospital Universitario Virgen Macarena | |
dc.page.number | 130-179 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Arterial hypertension | |
dc.subject | Atrial Fibrillation | |
dc.subject | Cardiovascular prevention | |
dc.subject | Diabetes | |
dc.subject | Dislipemia | |
dc.subject | Dyslipidaemia | |
dc.subject | Fibrilación auricular | |
dc.subject | Hipertensión arterial | |
dc.subject | Prevención cardiovascular | |
dc.subject | Smoking | |
dc.subject | Tabaquismo | |
dc.subject.mesh | Arteriosclerosis | |
dc.subject.mesh | Cardiovascular Diseases | |
dc.subject.mesh | Heart Disease Risk Factors | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Risk Factors | |
dc.title | SEA 2022 Standards for Global Control of Cardiovascular Risk. | |
dc.title.alternative | Estándares SEA 2022 para el control global del riesgo cardiovascular. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 34 | |
dspace.entity.type | Publication |